Published in Br Heart J on November 01, 1986
Cardiac damage in polymyositis associated with antibodies to tissue ribonucleoproteins. Br Heart J (1987) 0.84
Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia. Rheumatol Int (2006) 0.82
Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD Open (2016) 0.75
A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol (1979) 6.08
The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc Natl Acad Sci U S A (1984) 3.51
Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med (1983) 2.24
An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel. Histopathology (1984) 1.55
Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis. J Clin Lab Immunol (1982) 1.52
Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med (1985) 1.41
ECG abnormalities in polymyositis. Arch Intern Med (1984) 1.15
Cardiac abnormalities in polymyositis/dermatomyositis. Semin Arthritis Rheum (1982) 1.09
Immunological features of polymyositis/dermatomyositis. Springer Semin Immunopathol (1985) 0.92
The postviral fatigue syndrome--an analysis of the findings in 50 cases. J Infect (1985) 4.39
Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ (1991) 3.65
Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ (1992) 2.64
Myalgic encephalomyelitis--report of an epidemic. J R Coll Gen Pract (1983) 2.64
Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J R Soc Med (1988) 2.60
Epidemic myalgic encephalomyelitis. Practitioner (1980) 2.53
Strümpell's familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry (1974) 2.32
Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet (1976) 2.31
Postviral fatigue syndrome. Crit Rev Neurobiol (1988) 2.19
The symptoms of chronic fatigue syndrome are related to abnormal ion channel function. Med Hypotheses (2000) 2.10
Corporeal plication for surgical correction of Peyronie's disease. J Urol (1990) 2.03
Fatigue and basal ganglia. J Neurol Sci (2000) 1.82
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection. Clin Infect Dis (2001) 1.72
Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome. BMJ (1991) 1.69
The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer (2003) 1.58
'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain (1977) 1.56
Catheterisation: your urethra in their hands. BMJ (1990) 1.54
Myasthenic crisis. QJM (2008) 1.52
Serum folate and chronic fatigue syndrome. Neurology (1993) 1.47
Gangliosides and neurological diseases. BMJ (1992) 1.43
Uveitis and retinal vasculitis in acute experimental allergic encephalomyelitis in the Lewis rat: an ultrastructural study. Exp Eye Res (1993) 1.42
Acute cervical hyperextension-hyperflexion injury may precipitate and/or exacerbate symptomatic multiple sclerosis. Eur J Neurol (2001) 1.37
Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis. Neurology (1974) 1.35
Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand (1990) 1.33
Calcium-dependent polyphosphoinositide hydrolysis is associated with exocytosis in vitro. FEBS Lett (1985) 1.29
Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry (1990) 1.26
Ontogeny of peptide- and amine-containing neurones in motor, sensory, and autonomic regions of rat and human spinal cord, dorsal root ganglia, and rat skin. J Comp Neurol (1987) 1.23
Landry-Guillain-Barré-Strohl syndrome and immune-complex nephritis. Lancet (1973) 1.22
Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol (1991) 1.22
Neurological dysfunction in two patients receiving captopril and cimetidine. Lancet (1980) 1.20
Immune disease and HLA associations with myasthenia gravis. J Neurol Neurosurg Psychiatry (1980) 1.17
The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer. Br J Cancer (2004) 1.17
Amplification and identification of enteroviral sequences in the postviral fatigue syndrome. Br Med Bull (1991) 1.17
Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis. Lancet (1968) 1.17
Neurological aspects of mycoplasmal infection. Acta Neurol Scand (1986) 1.16
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol (1991) 1.11
Palatal myoclonus successfully treated with clonazepam. J Neurol Neurosurg Psychiatry (1990) 1.07
The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer. Br J Cancer (2006) 1.07
Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type. Ann N Y Acad Sci (1976) 1.04
Gene amplification and overexpression of HER2 in renal cell carcinoma. BJU Int (2002) 1.03
Letter: Immune response genes in myasthenia gravis. Lancet (1973) 1.02
Allergic encephalomyelitis: effect of complement depletion with cobra venom. Proc Soc Exp Biol Med (1971) 1.02
Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems. Br J Cancer (2011) 1.01
Immunologic mechanisms in experimental encephalomyelitis in nonhuman primates. Arch Neurol (1973) 1.00
In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids (2004) 0.99
Letter: Impaired cell-mediated immunity in human brain tumours. Lancet (1975) 0.98
Search for retrovirus in the chronic fatigue syndrome. J Clin Pathol (1992) 0.97
GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient. J Autoimmun (1999) 0.96
Letter: Rosette tests following thymectomy. Lancet (1975) 0.96
Late onset of Guillain-Barré syndrome. J Neuroimmunol (1982) 0.95
Nifedipine in the treatment of myotonia in myotonic dystrophy. J Neurol Neurosurg Psychiatry (1987) 0.95
Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis. Lancet (1979) 0.95
A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. Br J Clin Pharmacol (1990) 0.95
HLA-B8 in polymyositis. N Engl J Med (1978) 0.95
Cell-mediated hypersensitivity to neural antigens. Occurrence in human patients and nonhuman primates with neurological diseases. Arch Neurol (1972) 0.93
The role of viral infection in polymyositis, dermatomyositis and chronic fatigue syndrome. Baillieres Clin Neurol (1993) 0.93
A case of progressive encephalomyelitis with rigidity and positive antiglutamic acid decarboxylase antibodies [corrected]. J Neurol Neurosurg Psychiatry (1991) 0.93
Immunological features of polymyositis/dermatomyositis. Springer Semin Immunopathol (1985) 0.92
Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome. Eur J Neurol (1999) 0.92
Immunological studies in pre-eclamptic toxaemia. Br Med J (1976) 0.92
Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann N Y Acad Sci (2002) 0.91
Immunopathological mechanisms of allergic neuritis in animals, primates, and man. Trans Am Neurol Assoc (1969) 0.91
The ophthalmoplegic form of the Guillain-Barre-syndrome: an immunologic study. Acta Ophthalmol (Copenh) (1973) 0.91
Hyperacute experimental allergic neuritis. Res Commun Chem Pathol Pharmacol (1971) 0.91
Recurrent acute necrotizing hemorrhagic incephalopathy. Acta Neuropathol (1972) 0.90
Acute disseminated encephalomyelitis. Br J Clin Pract (1974) 0.89
Perineal excision of the rectum for prolapse in the elderly. Br J Surg (1991) 0.88
Diffuse myelitis associated with rubella vaccination. Br Med J (1977) 0.88
Behavioural problems associated with the chronic fatigue syndrome. Br J Psychol (1993) 0.88
Acute necrotizing hemorrhagic encephalopathy. Postgrad Med (1973) 0.88
Hereditary chorea without dementia. J Neurol Neurosurg Psychiatry (1977) 0.88
Brain damage complicating septic shock: acute haemorrhagic leucoencephalitis as a complication of the generalised Shwartzman reaction. J Neurol Neurosurg Psychiatry (1979) 0.87
Disturbance of regulatory lymphocyte subsets in polymyositis. Ann Neurol (1984) 0.87
Metabolism of immunoglobulin A, lymphocyte function, and histocompatibility antigens in patients on anticonvulsants. J Neurol Neurosurg Psychiatry (1978) 0.87
Cytoreductive nephrectomy: is it a realistic option in patients with renal cancer? BJU Int (2002) 0.87
Studies on enterovirus in patients with chronic fatigue syndrome. Clin Infect Dis (1994) 0.86
Enterovirus in the chronic fatigue syndrome. Ann Intern Med (1994) 0.86
Neuroanatomical anomalies in autoimmune mice. Acta Neuropathol (1987) 0.86
The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer. Br J Cancer (2006) 0.86
Brain abnormalities in immune defective mice. Brain Res (1990) 0.86
Treatment of multiple sclerosis: beyond the NICE guidelines. QJM (2005) 0.85
Letter: Decreased serum-IgA in myasthenia gravis. Lancet (1976) 0.85
Partial nephrectomy used to treat renal cell carcinoma arising in a live donor transplant kidney. Urol Res (2004) 0.85
Experimental autoimmune demyelinating diseases: experimental allergic encephalomyelitis and experimental allergic neuritis. Biomedicine (1975) 0.85
Abnormal extracellular material in the levator palpebrae superioris complex in congenital ptosis. Arch Ophthalmol (1995) 0.85